ArticlePharmaceutical research2012

MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.

Mingqian Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.